Carestream inks distributor deal, launches new C-PACS

Jeff Byers | | Health Imaging | Practice Management
Carestream Health has inked a multi-year contract with MedAssets Supply Chain Systems to provide health IT systems for purchase by MedAssets members, including data archiving, RIS/PACS and cardiology PACS.

Carestream also announced that its latest PACS delivers a unified virtual desktop with native 3D and applications—such as PowerViewer—that provide registration and volumetric matching of 3D studies.

The company said its Web-based Cardiology PACS offers a single integrated platform for diagnosis, image review and reporting for echocardiography, cardiac catheterization and nuclear cardiology procedures—while its SuperPACS Architecture links multi-vendor, multi-site PACS platforms to create an enterprise solution.



Jeff Byers

Related Content

Clinicians want AI to show its work
Multidose contrast injectors could increase waste in some radiology departments
Imaging leaders share 7 key considerations for remote scanning programs
Policies and regulations shaping radiology in 2025
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.